AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
-2.48%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$10.7B
AUM Growth
+$5.97B
(+126%)
Cap. Flow
+$6.2B
Cap. Flow
% of AUM
57.93%
Top 10 Holdings %
Top 10 Hldgs %
89.3%
Holding
662
New
163
Increased
138
Reduced
149
Closed
136
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$2.46B |
| 2 |
Invesco QQQ Trust
QQQ
|
$2.32B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$1.19B |
| 4 |
VanEck Semiconductor ETF
SMH
|
$699M |
| 5 |
Fortinet
FTNT
|
$684M |
Top Sells
| 1 |
TSMC
TSM
|
$1.11B |
| 2 |
Wells Fargo
WFC
|
$237M |
| 3 |
Bank of America
BAC
|
$222M |
| 4 |
JPMorgan Chase
JPM
|
$204M |
| 5 |
Global X Copper Miners ETF NEW
COPX
|
$159M |
Sector Composition
| 1 | Technology | 16.61% |
| 2 | Financials | 4.63% |
| 3 | Industrials | 2.96% |
| 4 | Consumer Discretionary | 1.21% |
| 5 | Consumer Staples | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Amphastar Pharmaceuticals
AMPH
$1.37B
| $101K | ﹤0.01% |
2,816
+549
| +24% | +$19.7K |
|
252
Alexandria Real Estate Equities
ARE
$14.5B
| $101K | ﹤0.01% |
500
-298
| -37% | -$60.2K |
|
253
Pfizer
PFE
$141B
| $100K | ﹤0.01% |
1,923
-92,544
| -98% | -$4.81M |
|
254
Gilead Sciences
GILD
$143B
| $99K | ﹤0.01% |
1,655
+969
| +141% | +$58K |
|
255
Incyte
INCY
$16.9B
| $97K | ﹤0.01% |
+1,226
| New | +$97K |
|
256
Exelixis
EXEL
$10.2B
| $95K | ﹤0.01% |
+4,182
| New | +$95K |
|
257
Eli Lilly
LLY
$652B
| $95K | ﹤0.01% |
31,606
-175
| -0.6% | -$526 |
|
258
Mettler-Toledo International
MTD
$26.9B
| $95K | ﹤0.01% |
69
-11
| -14% | -$15.1K |
|
259
Edwards Lifesciences
EW
$47.5B
| $94K | ﹤0.01% |
799
-276
| -26% | -$32.5K |
|
260
Hologic
HOLX
$14.8B
| $93K | ﹤0.01% |
1,208
+580
| +92% | +$44.7K |
|
261
Abbott
ABT
$231B
| $92K | ﹤0.01% |
776
+415
| +115% | +$49.2K |
|
262
Alpha and Omega Semiconductor
AOSL
$839M
| $92K | ﹤0.01% |
+1,691
| New | +$92K |
|
263
CONMED
CNMD
$1.7B
| $92K | ﹤0.01% |
617
+281
| +84% | +$41.9K |
|
264
Merck
MRK
$212B
| $92K | ﹤0.01% |
1,113
+452
| +68% | +$37.4K |
|
265
Stryker
SYK
$150B
| $92K | ﹤0.01% |
342
+159
| +87% | +$42.8K |
|
|
NXGN
266
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $92K | ﹤0.01% |
+4,384
| New | +$92K |
|
267
Amazon
AMZN
$2.48T
| $91K | ﹤0.01% |
560
-27,160
| -98% | -$4.41M |
|
268
Jack Henry & Associates
JKHY
$11.8B
| $90K | ﹤0.01% |
455
+180
| +65% | +$35.6K |
|
269
Lattice Semiconductor
LSCC
$9.05B
| $90K | ﹤0.01% |
1,470
-1,115
| -43% | -$68.3K |
|
270
Amgen
AMGN
$153B
| $89K | ﹤0.01% |
+369
| New | +$89K |
|
271
Becton Dickinson
BDX
$55.1B
| $89K | ﹤0.01% |
343
+86
| +33% | +$22.3K |
|
272
Morningstar
MORN
$10.8B
| $89K | ﹤0.01% |
327
-23
| -7% | -$6.26K |
|
273
Marvell Technology
MRVL
$54.6B
| $89K | ﹤0.01% |
1,248
-241
| -16% | -$17.2K |
|
274
S&P Global
SPGI
$164B
| $89K | ﹤0.01% |
216
-39
| -15% | -$16.1K |
|
|
SPLK
275
DELISTED
Splunk Inc
SPLK
| $89K | ﹤0.01% |
600
-555
| -48% | -$82.3K |
|